Latest stories on SLS
SELLAS Has $138 Million in Cash, but Its $150 Million ATM Still Shapes the Stock
TechStock²38 · neutralgeneral
Why Did SLS Stock Fall 14%? No New Filing, but Two Binary Catalysts Loom
TechStock²38 · neutralgeneral
Sellas Gears Up To Present Preclinical SLS009 Data For Pancreatic Cancer At Major Oncology Conference
Stocktwits News63 · neutralproduct/pr
Most and least shorted mid- to mega-cap healthcare stocks at the end of August
Seeking Alpha42 · neutralgeneral
Why Analysts Think Sellas Life Sciences Stock Can Gain 150% From Here
Barchart67 · bullishanalyst
Why Analysts Think Sellas Life Sciences Stock Can Gain 150% From Here
Yahoo Finance67 · bullishanalyst
Sellas CEO Stergiou Says ‘Rigorous, Unblinded’ Data From Pivotal AML Trial Will 'Speak For Itself' As REGAL Catalyst Nears
Stocktwits News58 · neutralproduct/pr
Sellas Life (SLS) Falls 13% as Firm Still Mum on ALM Drug Candidate
Yahoo Top34 · bearishgeneral
Sellas Traders See Pancreatic Cancer Race After RVMD’s Drug Approval — But Near-Term Focus Remains On SLS’s Leukemia Pipeline
Stocktwits News63 · neutralproduct/pr
SLS, IBRX Catch The Eye Of A Major US Pension Fund — And Big Clinical Catalysts Are On The Horizon
Stocktwits News56 · neutralgeneral
SLS Traders Eye This Important Resistance Zone Ahead Of Key AML Data Readout
Stocktwits News53 · neutralgeneral
SELLAS Life Sciences Stock (SLS) Has a Major Catalyst on the Horizon
TipRanks63 · neutralproduct/pr
SLS Stock Charges Ahead As AML Trial Buzz Builds: Report Claims Regal Hit 80th Event — Retail Isn’t Convinced
Stocktwits News58 · neutralgeneral
SLS Stock Clocks Three Straight Weeks Of Gains On Cancer Vaccine Spillover, REGAL Trial Data Anticipation
Stocktwits News73 · bullishproduct/pr
SLS Stock Edges Higher As Wall Street, Retail Expect Another MRNA Moment
Stocktwits News63 · neutralanalyst
Moderna data bode well for Sellas into imminent readout, says Maxim
The Fly63 · neutralanalyst
Sellas CEO Angelos Stergiou Highlights Pediatric Leukemia Study That ‘Directly Supports’ Scientific Basis Of Regal Trial
Stocktwits News56 · neutralproduct/pr
Goldman Sachs Builds $75M Bet Across CAPR, SLS And IBRX As Major Catalysts Loom
Stocktwits News58 · neutralgeneral
S&P 500, Nasdaq Futures Pause Near Record Highs: Why SPCX, AMAT, SNDK, CSCO, CAPR, SLS, ONDS Stocks Are In Focus
Stocktwits News56 · neutralgeneral
SLS And IBRX Eye Green Weekly Close: Vanguard’s Major Stakes In Cancer Drugmakers Steal The Spotlight
Stocktwits News55 · neutralgeneral
This One Data Readout Could Make Or Break Sellas Life Sciences Group
Seeking Alpha63 · neutralproduct/pr
SLS Stock Logs Best Day In Over A Week: JPMorgan Buys In And Stifel Boosts Bet Ahead Of Key AML Data
Stocktwits News67 · bullishanalyst
Sellas’ Experimental Drug SLS009 Appears To Be Leading The CDK9 Race, Says Alliance Global – Analyst Sees About 200% Upside Potential
Stocktwits News73 · bullishanalyst
Strong Cash Position Supports SELLAS as GPS and SLS009 Progress Toward Major Clinical Milestones
August 12, 2026
MarketChameleon67 · bullishproduct/pr